Augmedix, Inc. (AUGX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2024-10-04

Augmedix, Inc. (AUGX) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every AUGX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Augmedix, Inc. (AUGX)

SEC CIK	0001769804

Recent AUGX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2024-10-02	Traylor Margie L.	Director	D — Derivative transaction	124.1K	$2.35	$292K	SEC
2024-10-02	MCGRAW LAURIE	Director	D — Derivative transaction	74.2K	$2.35	$174K	SEC
2024-10-02	FEBBO WILLIAM J	Director	D — Derivative transaction	162.6K	$2.35	$382K	SEC
2024-10-02	Redmile Group, LLC	Director	D — Derivative transaction	16.42M	$2.35	$38.59M	SEC
2024-10-02	Redmile Group, LLC	Director	D — Derivative transaction	9.45M	$2.35	$22.20M	SEC
2024-10-02	Redmile Group, LLC	Director	D — Derivative transaction	6.22M	$2.35	$14.61M	SEC
2024-10-02	Faulkner Robert C.	Director	D — Derivative transaction	41.5K	$2.35	$97K	SEC
2024-10-02	Hawkins Jonathan	CHIEF REVENUE OFFICER	D — Derivative transaction	5.8K	$2.35	$14K	SEC
2024-10-02	Ginocchio Paul	CHIEF FINANCIAL OFFICER	D — Derivative transaction	135.8K	$2.35	$319K	SEC
2024-10-02	Breber Sandra	CHIEF OPERATING OFFICER	D — Derivative transaction	20.3K	$2.35	$48K	SEC
2024-10-02	Shakil Ian	CHIEF STRATEGY OFFICER	D — Derivative transaction	7.7K	$2.35	$18K	SEC
2024-10-02	Krakaris Emmanuel	PRESIDENT, CEO, AND SECRETARY	D — Derivative transaction	64.7K	$2.35	$152K	SEC
2024-10-02	O'Reilly Roderick H.	Director	D — Derivative transaction	21.6K	$2.35	$51K	SEC
2024-10-02	Chatterjee Saurav	CHIEF TECHNOLOGY OFFICER	D — Derivative transaction	5.8K	$2.35	$14K	SEC
2024-10-02	Krikorian Jason	Director	D — Derivative transaction	74.2K	$2.35	$174K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Augmedix, Inc. (AUGX). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2024-10-04 — MCGRAW LAURIE (Director)
2024-10-04 — FEBBO WILLIAM J (Director)
2024-10-04 — Redmile Group, LLC (Director)
2024-10-04 — Faulkner Robert C. (Director)
2024-10-04 — Traylor Margie L. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AUGX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

AUGX Insider Trading — FAQ

What is the latest insider trade for AUGX?: Augmedix, Inc. (AUGX) had 0 insider filings in the last 90 days, with the most recent on 2024-10-04. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying AUGX stock?: 0 insider purchases of AUGX were filed in the last 90 days.
How many insiders are selling AUGX stock?: 0 insider sales of AUGX were filed in the last 90 days.
Where can I see AUGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every AUGX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live AUGX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.